Company intelligence / Profile preview

Lanark Laboratories Pvt. Ltd.

Sirmaur / New Delhi, Himachal Pradesh / Delhi NCR region, Indiazeelab.co.in ↗

Ownership: Private
Development stage: Commercial

Overview

Lanark Laboratories is a commercial-stage pharmaceutical manufacturer with a diverse portfolio of generic medicines targeting pain management, anti-infectives, anti-parasitics, and other common indications. The company is recognized for its commitment to quality and innovation in drug manufacturing. No clinical trial data or novel therapeutics were identified.

Therapeutic areas: RheumatologyNeurologyInfectious Diseases
Modalities: Small molecules (tablets, injectables, creams, ointments)
Industry: Biotech

Drug pipeline

3 assets

aceclofenac

Commercial

Indications: Pain, Inflammation

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Lanark Laboratories Pvt. Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lanark Laboratories Pvt. Ltd..

Explore the full profile